Hemlibra 105 MG/0.7 ML vial 0.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26F19ST
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,001
Award facts
- Contract value 100% obligated
- $13,000.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of Hemlibra 105 mg/0.7 mL vials. The contract is valued at $13,000.80 with a firm fixed price structure and an ultimate completion date of January 12, 2026. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement that extends through December 2026 and serves as the company's primary vehicle for supplying pharmaceutical products and medical commodities to military healthcare systems worldwide.
Hemlibra is a specialized biopharmaceutical used in the treatment of hemophilia A, representing the type of critical therapeutic pharmaceutical that DLA procures to support Defense Health Agency operations and military medical readiness. The award demonstrates AmerisourceBergen's continued role as a key federal pharmaceutical supplier, with services performed at the company's Conshohocken, Pennsylvania facility. As a child delivery order under the larger IDC vehicle, this award leverages the framework established under DLA's Pharmaceutical Prime Vendor program to ensure efficient delivery of essential medications to support military healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F19ST?
SPE2DR26F19ST was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F19ST worth?
The government has obligated $13,001 on SPE2DR26F19ST.
Is contract SPE2DR26F19ST an order under another contract?
Yes. SPE2DR26F19ST is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19ST competed?
The extent of competition for SPE2DR26F19ST was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award